Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia

Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia

Abstract Aim Continued antipsychotic treatment is the key to preventing relapse. Maintenance antipsychotic monotherapy and optimal dose use are recommended for individuals with stable schizophrenia because of their undesirable effects. Decision aids (DAs) are clinical conversation tools that facilit...

Full description

Bibliographic Details
Main Authors: Yumi Aoki, Yoshikazu Takaesu, Kentaro Matsui, Takahiro Tokumasu, Hideaki Tani, Yoshiteru Takekita, Tetsufumi Kanazawa, Taishiro Kishimoto, Seiichiro Tarutani, Naoki Hashimoto, Hiroyoshi Takeuchi, Kazuo Mishima, Ken Inada
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Neuropsychopharmacology Reports
Subjects:
acceptability
antipsychotics
decision aid
schizophrenia
shared decision‐making
Online Access:https://doi.org/10.1002/npr2.12366

Internet

https://doi.org/10.1002/npr2.12366

Similar Items